mk 436 has been researched along with melarsoprol in 2 studies
| Studies (mk 436) | Trials (mk 436) | Recent Studies (post-2010) (mk 436) | Studies (melarsoprol) | Trials (melarsoprol) | Recent Studies (post-2010) (melarsoprol) |
|---|---|---|---|---|---|
| 20 | 0 | 0 | 459 | 21 | 138 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jennings, FW | 1 |
| Atouguia, JM; Jennings, FW; Murray, M | 1 |
1 review(s) available for mk 436 and melarsoprol
| Article | Year |
|---|---|
Combination chemotherapy of CNS trypanosomiasis.
Topics: Arsenicals; Central Nervous System Diseases; Drug Therapy, Combination; Humans; Melarsoprol; Nitroimidazoles; Trypanocidal Agents; Trypanosomiasis, African | 1993 |
1 other study(ies) available for mk 436 and melarsoprol
| Article | Year |
|---|---|
Topical chemotherapy for experimental murine African CNS-trypanosomiasis: the successful use of the arsenical, melarsoprol, combined with the 5-nitroimidazoles, fexinidazole or MK-436.
Topics: Administration, Topical; Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Combinations; Female; Gels; Melarsoprol; Mice; Nitroimidazoles; Trypanocidal Agents; Trypanosomiasis, African | 1996 |